DCPLA-ME structure
|
Common Name | DCPLA-ME | ||
|---|---|---|---|---|
| CAS Number | 56687-67-3 | Molecular Weight | 322.52500 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C21H38O2 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of DCPLA-MEDCPLA-ME, the methyl ester form of DCPLA, is a potent PKCε activator for use in the treatment of neurodegenerative diseases[1]. |
| Name | DCPLA methyl ester |
|---|---|
| Synonym | More Synonyms |
| Description | DCPLA-ME, the methyl ester form of DCPLA, is a potent PKCε activator for use in the treatment of neurodegenerative diseases[1]. |
|---|---|
| Related Catalog | |
| Target |
PKCε |
| References |
| Molecular Formula | C21H38O2 |
|---|---|
| Molecular Weight | 322.52500 |
| Exact Mass | 322.28700 |
| PSA | 26.30000 |
| LogP | 6.13270 |
| 8-[2-(2-pentylcyclopropylmethyl)cyclopropyl]octanoic acid methyl ester |
| methyl 8-(2-((2-pentylcyclopropyl)methyl)cyclopropyl)octanoate |
| 9,10,12,13-Dimethylen-octadecansaeure-methylester |
| 8-[2-(2-Pentyl-cyclopropylmethyl)-cyclopropyl]-octanoic acid methyl ester |